|
 Contact us regarding Trasylol; attorney consultations are free.
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature. read more »
Jul. 2, 07: Accident Raises Safety Concerns About Chinese Tires
Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature read more »
Feb. 8, 06: FDA Issues Public Health Advisory for Trasylol
FDA issued a Public Health Advisory alerting doctors who perform heart bypass surgery, and their patients, that Trasyolol (aprotinin injection), a drug used to prevent blood loss during surgery, has b... read more »
What is Trasylol?
Trasylol, which has the generic name of aprotinin injection, is manufactured by Bayer AG. Trasylol is a drug used to prevent perioperative blood loss and the need for blood transfusion, in patients undergoing a procedure called coronary artery bypass grafting surgery. This type of heart surgery redirects the blood around clogged arteries, in order to increase the blood-flow and oxygen to the heart. Trasylol is known as a broad-spectrum proteinase inhibitor. The drug is designed to work by blocking the enzymes in the body that dissolve blood clots. Trasylol received approval by the FDA in 1993. Worldwide Trasylol sales were approximately $210 million for 2005.
Contact us regarding Trasylol; attorney consultations are free.
« Back to Trasylol page
|
|
| | |
